1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
  4. > Vital Signs - The Analyst's Perspective - March 2015 Issue

Vital Signs - The Analyst's Perspective - March 2015 Issue

  • April 2015
  • -
  • Frost & Sullivan
  • -
  • 7 pages

This issue of Vital Signs, released on April 3, 2015, discusses next-generation sequencing bioinformatics partnerships, FDA approval of Novartis's ZARXIO, 23andMe's foray into drug development, and Johnson & Johnson's sale of Cordis to Cardinal Health.

NGS Bioinformatics Partnerships Heat Up

Source: Cartagenia and Tute Genomics, March 17, 2015
On March 17, two announcements emerged concerning next-generation sequencing (NGS) informatics companies teaming up to provide complete workflows. DNAnexus and Tute Genomics joined forces, while Cartegenia and N-of-One will integrate their offerings as well. DNAnexus and Tute Genomics have teamed up to provide an integrated solution for upstream primary analyses and downstream interpretation along the NGS bioinformatics workflow. DNAnexus, based in Mountain View, Calif., provides a configurable cloud-based platform for storage, computing, and NGS primary and secondary data analysis. Tute Genomics, based in Provo, Utah, provides a cloud-based solution for genome annotation and clinical interpretation and reporting.

The combined offering streamlines data transfer between the two offerings so end users can easily transfer variant data from DNAnexus to Tute’s platform for downstream analysis. Cartegnia, based in Cambridge, Mass., offers its Bench Lab NGS platform, which manages NGS data, performs variant calling, and puts variants into patient-related information and phenotypic context. N-of-One provides clinical interpretation services of NGS data. The combined offering is aimed at pathology labs, allowing them to
integrate N-of-One’s genomic and tumor intreprations into their Bench Lab NGS platforms.

Table Of Contents

Vital Signs - The Analyst's Perspective - March 2015 Issue
LIFE SCIENCES
NGS Bioinformatics Partnerships Heat Up . 2
Who Wins with Recent FDA Approval of Novartis's ZARXIO Biosimilar?. 3
In Big Shift, 23andMe will Invent Drugs Using Customer Data. 4
JandJ Sells Cordis to Cardinal: A Worthy Investment?. 6

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets

Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets

  • $ 6650
  • Industry report
  • January 2017
  • by BCC Research

Use this report to: - Assess current market dynamics and estimate future demand for sample preparation in genomics, proteomics and epigenomics. - Gain insight into existing products as well as new developments ...

Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics) And Trend Analysis From 2013 To 2025

Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics) And Trend Analysis From 2013 To 2025

  • $ 4950
  • Industry report
  • January 2017
  • by Grand View Research

The global predictive genetic testing & consumer/wellness genomics market is anticipated to reach USD 4.6 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing ...

CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use And Segment Forecasts, 2014 - 2025

CRISPR And CRISPR-Associated (Cas) Genes Market Analysis By Product (Vector-Based & DNA-Free Cas), By Application (Genome Engineering, Disease Models, Functional Genomics), By End-Use And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • January 2017
  • by Grand View Research

The Clustered regularly interspaced short palindromic repeats CRISPR and CRISPR-associated (Cas) genes market is anticipated to reach USD 4.09 billion by 2025, according to a new report by Grand View Research, ...


Download Unlimited Documents from Trusted Public Sources

DNA Industry in the US

  • March 2017
    13 pages
  • DNA  

  • United States  

View report >

Genetic Industry in China

  • March 2017
    25 pages
  • Genetic  

    Genetic Disorde...  

  • China  

View report >

Genetic Industry in Africa

  • March 2017
    12 pages
  • Genetic  

  • Africa  

    United States  

View report >

Genomics Statistics

13 days ago

Related Market Segments :

Genomics
Bioinformatic

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.